Long-term lithium treatment can reduce the kidneys’ ability to conserve water, causing excessive urination and thirst. This condition is called lithium-induced nephrogenic diabetes insipidus (NDI), also known as arginine vasopressin resistance.
Lithium can also contribute to chronic kidney disease (CKD) in some patients, but these are not the same complication. A person can develop difficulty concentrating urine while their kidney filtration tests remain relatively normal.
The most important precautions are regular kidney function tests, appropriate lithium blood-level monitoring, and early evaluation of persistent thirst or unusually frequent urination.
Do not stop lithium suddenly or change your dose without medical guidance. Lithium can be highly effective for bipolar disorder, and treatment decisions must balance psychiatric stability with kidney safety.
What Is Lithium-Induced Nephrogenic Diabetes Insipidus?
Lithium is a mood-stabilizing medication commonly used to treat bipolar disorder. It can help control mood episodes and reduce the risk of relapse.
However, lithium is removed from the body primarily through the kidneys. Over time, it can interfere with the kidneys’ ability to retain water.
Normally, a hormone called vasopressin, also known as antidiuretic hormone (ADH), tells the kidneys to conserve water when the body needs it.
In nephrogenic diabetes insipidus, the kidneys do not respond adequately to this hormone.
As a result, they release unusually large amounts of dilute urine.
This can cause:
- Frequent urination throughout the day
- Waking repeatedly at night to urinate
- Persistent or excessive thirst
- Drinking unusually large quantities of water
- Dehydration when fluid intake cannot match urine losses
Despite its name, nephrogenic diabetes insipidus is not the same as diabetes mellitus, which involves blood glucose regulation.
The two conditions have different causes and require different evaluations.
How Does Lithium Affect the Kidneys?
Lithium can enter specialized kidney cells through channels involved in sodium transport.
These cells are located in the collecting ducts, where the kidneys make final adjustments to urine concentration.
Under normal conditions, vasopressin helps these cells place water channels called aquaporin-2 into their membranes.
These channels allow water to move back into the body instead of being lost in urine.
Lithium can interfere with this process.
Over time, the kidneys may become less responsive to vasopressin, reducing their ability to concentrate urine.
The result is increased water loss.
Does This Mean Lithium Permanently Damages the Kidneys?
Not necessarily.
Lithium-related kidney effects vary considerably.
Some patients develop relatively mild concentrating problems that improve after treatment changes.
Others experience persistent nephrogenic diabetes insipidus, particularly after prolonged exposure.
A smaller proportion develop progressive chronic kidney disease associated with long-term lithium treatment.
These complications are related but distinct.
Nephrogenic diabetes insipidus primarily affects water regulation, while chronic kidney disease involves persistent abnormalities in kidney structure or function.
Having NDI does not automatically mean someone will develop kidney failure.
What Are the Early Warning Signs?
The most recognizable symptoms are excessive urination and increased thirst.
However, not everyone who urinates frequently has nephrogenic diabetes insipidus.
Frequent urination may also occur because of:
- High blood glucose
- Urinary tract infections
- Diuretic medications
- Excessive fluid intake
- Bladder conditions
- Sleep-related problems
A useful distinction is whether someone is passing unusually large amounts of urine or simply urinating frequently in small amounts.
In NDI, total daily urine volume is typically increased.
For adults, urine output exceeding approximately 3 liters per day may prompt evaluation for polyuria, although body size and clinical circumstances matter.
A patient who develops persistent thirst, frequent nighttime urination, or noticeably increased urine volume while taking lithium should discuss these changes with their clinician.
Which Tests Help Diagnose Lithium-Induced NDI?
Diagnosis requires more than noticing frequent urination.
Clinicians assess symptoms, medication history, blood chemistry, and the kidneys’ ability to concentrate urine.
1. Blood Sodium
Sodium helps regulate the balance of water inside and outside the body’s cells.
When a person loses more water than they replace, sodium levels may rise.
This is called hypernatremia.
However, sodium can remain normal in someone with NDI who drinks enough water to compensate for urine losses.
Therefore, a normal sodium result does not exclude the condition.
2. Urine Osmolality
Urine osmolality measures how concentrated or diluted urine is.
People with impaired urine concentration may produce unusually dilute urine even when their bodies need to conserve water.
Clinicians interpret this result alongside blood sodium, serum osmolality, urine volume, and fluid intake.
3. Serum Creatinine and eGFR
Creatinine is a waste product used to estimate kidney filtration.
eGFR estimates how effectively the kidneys filter blood.
These tests help monitor overall kidney function, but they do not directly measure the kidneys’ ability to concentrate urine.
A person can have lithium-induced NDI even when eGFR remains within the normal range.
4. Lithium Blood Level
Lithium has a narrow therapeutic range, meaning the difference between effective and potentially harmful blood concentrations can be relatively small.
Blood testing helps clinicians determine whether lithium exposure is appropriate.
Results must be interpreted according to the prescribed regimen and the timing of the blood sample.
A lithium level within the prescribed target range does not completely eliminate the possibility of long-term kidney effects.
5. Specialized Testing
In selected cases, clinicians may use supervised testing to distinguish nephrogenic diabetes insipidus from other causes of excessive urination.
Water-deprivation testing and tests involving vasopressin-related pathways may be considered.
Never attempt a water-deprivation test at home. Restricting water in someone with suspected NDI can cause dangerous dehydration and hypernatremia.
How Often Should Kidney Function Be Monitored During Lithium Treatment?
Regular monitoring is essential because kidney changes may develop gradually.
Many clinical guidelines recommend checking kidney function approximately every six months during stable lithium treatment, with more frequent testing when risk factors or abnormal results are present.
A monitoring plan may include:
- Serum creatinine and eGFR: To follow kidney filtration over time.
- Lithium blood levels: To maintain an appropriate therapeutic concentration.
- Blood sodium and other electrolytes: To identify fluid-balance abnormalities.
- Calcium: Because lithium can contribute to elevated calcium through effects on the parathyroid glands.
- Urine concentration testing: When excessive thirst or urination suggests impaired water regulation.
The schedule may change depending on age, kidney function, other medications, recent illness, and treatment stability.
Patients with declining eGFR, repeated lithium toxicity, or symptoms suggesting NDI may require closer monitoring.
Why Kidney Function Trends Matter
A single creatinine or eGFR result cannot establish whether kidney damage is progressing.
For example, a small change in eGFR may reflect normal biological variation, hydration differences, or temporary illness.
A sustained decline over several measurements deserves more attention.
Clinicians consider the previous result, current result, size of the change, time interval, and other kidney findings.
Persistent abnormalities may justify evaluation by a nephrologist.
Can Lithium-Induced NDI Be Reversed?
Sometimes, but recovery is unpredictable.
In some patients, the kidneys’ ability to concentrate urine improves when lithium exposure is reduced or discontinued under medical supervision.
However, concentrating defects can persist, especially after many years of treatment.
Recovery depends on several factors, including the duration of lithium exposure, severity of the concentrating defect, and presence of other kidney abnormalities.
There is no reliable timeline that applies to everyone.
Importantly, stopping lithium does not guarantee that kidney function will return to normal.
For patients whose psychiatric condition has responded well to lithium, the risks of stopping treatment may also be substantial.
Treatment decisions should involve the prescribing mental health clinician and, when appropriate, a nephrologist.
How Is Lithium-Induced NDI Managed?
Management focuses on preventing dehydration, reducing complications, and preserving both kidney function and mental health stability.
Maintaining Appropriate Hydration
People with NDI may need access to sufficient water to replace excessive urine losses.
However, fluid recommendations must reflect individual medical circumstances.
Patients with heart failure, advanced kidney disease, or other fluid-balance disorders may require specialized guidance.
Sudden fluid restriction can be dangerous in someone with significant NDI.
Reviewing Lithium Treatment
The prescribing clinician may reassess lithium blood levels, treatment necessity, and the overall risk-benefit balance.
In selected patients, adjustments to the treatment regimen may be considered.
These decisions must be individualized because poorly controlled bipolar disorder can have serious consequences.
Considering Amiloride
Amiloride is a potassium-sparing diuretic that may help reduce lithium-induced urine-concentrating problems.
It blocks sodium channels through which lithium can enter certain kidney cells.
By limiting lithium entry, amiloride may reduce some of its effects on water regulation.
However, amiloride can increase blood potassium, particularly in people with reduced kidney function or those taking other potassium-raising medications.
It requires appropriate medical supervision and laboratory monitoring.
Other Treatment Options
Thiazide diuretics are sometimes used to reduce excessive urine output in selected patients.
However, they can increase lithium concentrations and cause electrolyte disturbances.
Their use requires careful specialist management.
Other treatments may be considered in specific circumstances, but no medication reliably reverses all cases of lithium-induced NDI.
Does Long-Term Lithium Use Cause Chronic Kidney Disease?
Long-term lithium treatment is associated with an increased risk of chronic kidney disease in some patients.
However, the risk varies, and many people taking lithium maintain relatively stable kidney function for years.
Factors associated with greater concern include:
- Longer duration of lithium exposure
- Previous episodes of lithium toxicity
- Existing kidney impairment
- Older age
- Hypertension or diabetes
- Other medications or illnesses affecting kidney function
Lithium-associated chronic kidney disease may involve gradual structural changes in kidney tissue.
Nevertheless, a declining eGFR in someone taking lithium does not automatically prove lithium is the cause.
Other kidney conditions must also be considered.
The decision to continue lithium should be based on the overall pattern of kidney function, psychiatric benefits, alternative treatments, and patient preferences.
What Can Increase the Risk of Lithium Toxicity?
Lithium concentrations can rise when the kidneys remove less lithium than usual.
Important contributing factors include dehydration, acute kidney injury, and interactions with certain medications.
Examples include:
- Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen
- ACE inhibitors and angiotensin receptor blockers
- Certain diuretics
- Significant vomiting or diarrhea
- Sudden changes in kidney function
Major changes in sodium intake or fluid balance can also affect lithium handling.
Do not independently alter your lithium dose or discontinue prescribed medications. Contact your prescribing clinician promptly when significant illness, dehydration, or medication changes occur.
When Should You Seek Urgent Medical Attention?
Seek urgent medical assessment if you develop persistent vomiting, severe dehydration, inability to maintain fluid intake, or symptoms suggesting lithium toxicity.
Possible lithium toxicity symptoms include worsening tremor, unsteady walking, muscle weakness, confusion, and unusual drowsiness.
Severe confusion, seizures, fainting, or marked difficulty walking require emergency care.
A person with NDI who cannot drink enough water to replace urine losses may develop dangerously high sodium levels.
These situations should not wait for a routine appointment.
Practical Steps for Patients Taking Lithium
Long-term kidney protection depends on consistent monitoring and early recognition of changes.
- Keep scheduled lithium blood tests. Correct sampling times are important for interpretation.
- Track kidney function trends. Ask about changes in creatinine and eGFR over time.
- Report persistent thirst or excessive urination. These symptoms may require urine concentration testing.
- Maintain consistent hydration habits. Avoid dehydration and follow individualized fluid advice.
- Review new medications before taking them. Some common painkillers and blood pressure medicines interact with lithium.
- Discuss illness promptly. Vomiting, diarrhea, fever, or reduced fluid intake can increase lithium-related risks.
- Ask whether specialist review is needed. A nephrologist may help when kidney function declines or NDI becomes difficult to manage.
Frequently Asked Questions
Can lithium cause excessive urination without kidney failure?
Yes.
Lithium can interfere with urine concentration even when kidney filtration remains relatively normal.
This is why symptoms and urine testing may reveal problems that creatinine and eGFR alone cannot identify.
Is lithium-induced nephrogenic diabetes insipidus permanent?
Not always.
Some patients improve after clinician-directed treatment changes, while others have persistent concentrating problems.
The outcome depends on the severity and duration of kidney effects.
Can drinking more water cure lithium-induced NDI?
No.
Drinking sufficient water can help replace fluid losses and prevent dehydration, but it does not correct the underlying kidney response to vasopressin.
Management may require medication review and specialist treatment.
Should lithium be stopped if eGFR declines?
Not automatically.
A declining eGFR requires evaluation, but treatment decisions depend on the rate of change, other kidney findings, psychiatric stability, and available alternatives.
The prescribing clinician and nephrologist may work together to determine the safest approach.
Can NDI occur with a normal lithium blood level?
Yes.
Long-term lithium-related concentrating problems can occur even when blood lithium concentrations remain within the prescribed therapeutic range.
A normal lithium level does not replace monitoring for kidney-related symptoms.
Bottom Line
Lithium can affect the kidneys in two important ways: it may impair their ability to conserve water, causing nephrogenic diabetes insipidus, and it may contribute to chronic kidney disease in some long-term users.
These complications are not inevitable, and they do not always occur together.
Regular lithium blood-level testing, kidney function monitoring, and early evaluation of excessive thirst or urination are central to safer long-term treatment.
Some lithium-related concentrating problems improve with treatment changes, while others may persist.
The goal is not simply to avoid lithium at all costs. It is to protect kidney health while maintaining effective treatment for the psychiatric condition for which lithium was prescribed.
Medical disclaimer: This article is for educational purposes only and does not replace individualized advice from a psychiatrist, nephrologist, or other qualified healthcare professional. Never stop or change lithium treatment without medical supervision.